Share on StockTwits

BTG plc (LON: BTG) received a number of ratings updates from brokerages and research firms in the last week:

  • BTG plc had its “hold” rating reaffirmed by analysts at Jefferies Group. They now have a GBX 525 ($8.84) price target on the stock.
  • BTG plc had its “buy” rating reaffirmed by analysts at Investec. They now have a GBX 723 ($12.17) price target on the stock.
  • BTG plc had its “sell” rating reaffirmed by analysts at N+1 Singer. They now have a GBX 486 ($8.18) price target on the stock, down previously from GBX 488 ($8.21).
  • BTG plc had its “sell” rating reaffirmed by analysts at FinnCap.
  • BTG plc had its price target lowered by analysts at N+1 Singer from GBX 488 ($8.21) to GBX 486 ($8.18). They now have a “sell” rating on the stock.
  • BTG plc had its “buy” rating reaffirmed by analysts at Deutsche Bank. They now have a GBX 655 ($11.03) price target on the stock.

BTG plc (LON:BTG) opened at 582.00 on Tuesday. BTG plc has a 52 week low of GBX 351.20 and a 52 week high of GBX 624.00. The stock has a 50-day moving average of GBX 538.7 and a 200-day moving average of GBX 556.5.

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.